Becton Dickinson & Co (BDX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
Becton, Dickinson and Company (BDX)
Last becton, dickinson and company earnings: 2/6 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bd.com
Company Research
Source: Yahoo! Finance
Adjusted Operating Margin: 24.2% for the full year, 26.6% for Q4. Free Cash Flow: $3.1 billion, a 47% increase. BD Medical Segment Growth: Driven by infusion systems and prefilled devices for biologic drugs. BD Life Sciences Growth: Led by specimen management and molecular platform growth. BD Interventional Growth: Double-digit growth in PureWick franchise and advanced repair and reconstruction. Net Leverage: 3 times, with a target to reduce to 2.5 times in 12-18 months. Fiscal Year 2025 Revenue Guidance: $21.9 billion to $22.1 billion, with 8.8% to 9.3% currency-neutral growth. Fiscal Year 2025 Adjusted EPS Guidance: $14.25 to $14.60. Warning! GuruFocus has detected 5 Warning Sign with BDX. Release Date: November 07, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript Becton Dickinson & Co ( NYSE:BDX ) reported strong Q4 results with 7.4% revenue growth and 11.4% increase in adjusted diluted EPS. The compan
Show less
Read more
Impact Snapshot
Event Time:
BDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BDX alerts
High impacting Becton, Dickinson and Company news events
Weekly update
A roundup of the hottest topics
BDX
News
- Flow Cytometry Market Expected To Reach USD 11553.44 Mn by 2032, Growing at 8.21% CAGR | Introspective Market Research [Yahoo! Finance]Yahoo! Finance
- First of Its Kind HPV Self-Collection Study Launched to Improve Cervical Cancer Screening in Underserved Communities [Yahoo! Finance]Yahoo! Finance
- First of Its Kind HPV Self-Collection Study Launched to Improve Cervical Cancer Screening in Underserved CommunitiesPR Newswire
- BD to Present at the 7th Annual Evercore ISI HealthCONx ConferencePR Newswire
- Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio [Yahoo! Finance]Yahoo! Finance
BDX
Earnings
- 11/7/24 - Beat
BDX
Sec Filings
- 11/7/24 - Form 8-K
- 11/5/24 - Form 4
- 11/5/24 - Form 4
- BDX's page on the SEC website